Patents by Inventor Kevin M. Ulmer

Kevin M. Ulmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030138831
    Abstract: The present invention relates to methods for sequencing a polymeric biomolecule and methods for structurally characterizing the same comprising using aptamers. In a preferred embodiment of this invention, these methods relate to using the single polymeric biomolecule. The invention also relates to a method for selecting aptamers useful for sequencing nucleic acids and aptamers generated by the method. The invention also provides aptamers that recognize and bind to AMP, dAMP, GMP, dGMP, CMP and dCMP.
    Type: Application
    Filed: December 3, 2002
    Publication date: July 24, 2003
    Applicant: Praelux Incorporated
    Inventors: Jae-Gyu Kwagh, John J. Macklin, Paul G. Mitsis, Kevin M. Ulmer
  • Patent number: 6515120
    Abstract: The present invention relates to methods for sequencing a polymeric biomolecule and methods for structurally characterizing the same comprising using aptamers. In a preferred embodiment of this invention, these methods relate to using the single polymeric biomolecule. The invention also relates to a method for selecting aptamers useful for sequencing nucleic acids and aptamers generated by the method. The invention also provides aptamers that recognize and bind to AMP, dAMP, GMP, dGMP, CMP and dCMP.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: February 4, 2003
    Assignee: Praelux Incorporated
    Inventors: Jae-Gyu Kwagh, John J. Macklin, Paul G. Mitsis, Kevin M. Ulmer
  • Patent number: 6296810
    Abstract: The present invention provides a method and apparatus for automated DNA sequencing. The method of the invention includes the steps of: a) using a processive exonuclease to cleave from a single DNA strand the next available single nucleotide on the strand; b) transporting the single nucleotide away from the DNA strand; c) incorporating the single nucleotide in a fluorescence-enhancing matrix; d) irradiating the single nucleotide to cause it to fluoresce; e) detecting the fluorescence; f) identifying the single nucleotide by its fluorescence; and g) repeating steps a) to f) indefinitely (e.g., until the DNA strand is fully cleaved or until a desired length of the DNA is sequenced).
    Type: Grant
    Filed: June 18, 1997
    Date of Patent: October 2, 2001
    Assignee: Praelux Incorporated
    Inventor: Kevin M. Ulmer
  • Patent number: 5776674
    Abstract: An optical trap is used to translate a particle through a thin film coating on an optically-flat surface. Preferably, the thin film coating is heterogeneous and the optical trap is used to move the particle through a succession of different regions of the thin film coating where different chemical, biochemical and/or biological processes take place. Examples of chemical, biochemical and/or biological processes that might be implemented in accordance with the invention include the following: oligonucleotide synthesis and sequencing, peptide synthesis and sequencing, carbohydrate synthesis and sequencing, combinatorial library synthesis and screening, conventional (i.e., Sanger or Maxam-Gilbert) DNA sequengcing, or single-molecule DNA sequencing. In one embodiment of the invention, reaction products are left behind as the particle is moved through the thin film coating. Advantageously, these products can be identified by suitable means.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: July 7, 1998
    Assignee: SEQ, Ltd
    Inventor: Kevin M. Ulmer
  • Patent number: 5741650
    Abstract: The present invention provides methods for screening for the presence of a subpopulation of cancerous or precancerous cells in a heterogeneous cellular sample, such as a stool sample. The methods take advantage of the recognition that cellular debris from cancerous and precancerous cells is deposited onto only a longitudinal stripe of stool as the stool is forming in the colon. Accordingly, methods of the invention comprise obtaining a representative sample, such as a cross-sectional sample of stool in order to ensure that any cellular debris that is shed by colonic cells is obtained in the sample.
    Type: Grant
    Filed: August 14, 1996
    Date of Patent: April 21, 1998
    Assignee: Exact Laboratories, Inc.
    Inventors: Stanley N. Lapidus, Anthony P. Shuber, Kevin M. Ulmer
  • Patent number: 5674743
    Abstract: The present invention provides a method and apparatus for automated DNA sequencing. The method of the invention includes the steps of: a) using a processive exonuclease to cleave from a single DNA strand the next available single nucleotide on the strand; b) transporting the single nucleotide away from the DNA strand; c) incorporating the single nucleotide in a fluorescence-enhancing matrix; d) irradiating the single nucleotide to cause it to fluoresce; e) detecting the fluorescence; f) identifying the single nucleotide by its fluorescence; and g) repeating steps a) to f) indefinitely (e.g., until the DNA strand is fully cleaved or until a desired length of the DNA is sequenced).
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 7, 1997
    Assignee: SEQ, Ltd.
    Inventor: Kevin M. Ulmer
  • Patent number: 5670325
    Abstract: Methods are provided for detecting the presence of mutant sequences in a subpopulation of gene sequences in a biological sample. These methods are particularly useful for identifying individuals with gene mutations indicative of early colorectal cancer.
    Type: Grant
    Filed: August 14, 1996
    Date of Patent: September 23, 1997
    Assignee: Exact Laboratories, Inc.
    Inventors: Stanley N. Lapidus, Anthony P. Shuber, Kevin M. Ulmer